CU23575A1 - Composición farmacéutica que comprende la proteína nmb0606 - Google Patents
Composición farmacéutica que comprende la proteína nmb0606Info
- Publication number
- CU23575A1 CU23575A1 CU20060075A CU20060075A CU23575A1 CU 23575 A1 CU23575 A1 CU 23575A1 CU 20060075 A CU20060075 A CU 20060075A CU 20060075 A CU20060075 A CU 20060075A CU 23575 A1 CU23575 A1 CU 23575A1
- Authority
- CU
- Cuba
- Prior art keywords
- composition
- nmb0606
- pharmaceutical composition
- composition including
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona con el campo de la medicina, particularmente con el desarrollo de una composición farmacéutica que comprende la proteína NMB0606. La composición de la presente invención confiere protección contra diferentes enfermedades, causadas o no por patógenos. La proteína NMB0606 se identificó como componente de las preparaciones de vesículas de membrana externa (VME) de Neisseria meningitidis, se obtuvo mediante la tecnología del ácido desoxirribonucleico (ADN) recombinante y se evaluó su inmunogenicidad y actividad protectora en modelos animales. Por el elevado grado de conservación del gen que codifica para la proteína NMB0606, la composición que la comprende posee alto valor como antígeno inductor de una respuesta inmune de amplia reactividad. La composición de esta invención es aplicable en la medicina humana.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060075A CU23575A1 (es) | 2006-03-31 | 2006-03-31 | Composición farmacéutica que comprende la proteína nmb0606 |
ARP070101323A AR060797A1 (es) | 2006-03-31 | 2007-03-29 | Composicion farmaceutica que comprende la proteina nmb0606 |
AU2007234214A AU2007234214A1 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the NMB0606 protein |
PCT/CU2007/000013 WO2007112703A2 (es) | 2006-03-31 | 2007-03-29 | Composición farmacéutica que comprende la proteína nmb0606 |
US12/295,198 US20100129387A1 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the nmb0606 protein |
CA002647465A CA2647465A1 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the nmb0606 protein |
EP07721809A EP2011509A2 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical composition containing the nmb0606 protein |
KR1020087026335A KR20080108576A (ko) | 2006-03-31 | 2007-03-29 | Nmb0606 단백질을 포함하는 약학적 조성물 |
CNA2007800182864A CN101448518A (zh) | 2006-03-31 | 2007-03-29 | 含有nmb0606蛋白的药物组合物 |
MX2008012665A MX2008012665A (es) | 2006-03-31 | 2007-03-29 | Composicion farmaceutica que comprende la proteina nmb0606. |
BRPI0709922-3A BRPI0709922A2 (pt) | 2006-03-31 | 2007-03-29 | composiÇço farmacÊutica contendo a proteÍna nmb0606 |
ZA200808768A ZA200808768B (en) | 2006-03-31 | 2008-10-14 | Pharmaceutical composition containing the NMB0606 protein |
NO20084525A NO20084525L (no) | 2006-03-31 | 2008-10-28 | Farmasoytiske sammensetninger inneholdende NMB0606-protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060075A CU23575A1 (es) | 2006-03-31 | 2006-03-31 | Composición farmacéutica que comprende la proteína nmb0606 |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23575A1 true CU23575A1 (es) | 2010-09-30 |
Family
ID=38535626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20060075A CU23575A1 (es) | 2006-03-31 | 2006-03-31 | Composición farmacéutica que comprende la proteína nmb0606 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100129387A1 (es) |
EP (1) | EP2011509A2 (es) |
KR (1) | KR20080108576A (es) |
CN (1) | CN101448518A (es) |
AR (1) | AR060797A1 (es) |
AU (1) | AU2007234214A1 (es) |
BR (1) | BRPI0709922A2 (es) |
CA (1) | CA2647465A1 (es) |
CU (1) | CU23575A1 (es) |
MX (1) | MX2008012665A (es) |
NO (1) | NO20084525L (es) |
WO (1) | WO2007112703A2 (es) |
ZA (1) | ZA200808768B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190044663A (ko) | 2016-09-02 | 2019-04-30 | 사노피 파스퇴르 인크 | 네이세리아 메닌기티디스 백신 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102580072A (zh) * | 1999-05-19 | 2012-07-18 | 诺华疫苗和诊断有限公司 | 组合式奈瑟球菌组合物 |
GB0103424D0 (en) * | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
CU23236A1 (es) * | 2003-12-03 | 2007-09-26 | Ct Ingenieria Genetica Biotech | PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P |
-
2006
- 2006-03-31 CU CU20060075A patent/CU23575A1/es unknown
-
2007
- 2007-03-29 MX MX2008012665A patent/MX2008012665A/es unknown
- 2007-03-29 US US12/295,198 patent/US20100129387A1/en not_active Abandoned
- 2007-03-29 AU AU2007234214A patent/AU2007234214A1/en not_active Abandoned
- 2007-03-29 EP EP07721809A patent/EP2011509A2/en not_active Withdrawn
- 2007-03-29 AR ARP070101323A patent/AR060797A1/es not_active Application Discontinuation
- 2007-03-29 WO PCT/CU2007/000013 patent/WO2007112703A2/es active Search and Examination
- 2007-03-29 KR KR1020087026335A patent/KR20080108576A/ko not_active Application Discontinuation
- 2007-03-29 BR BRPI0709922-3A patent/BRPI0709922A2/pt not_active IP Right Cessation
- 2007-03-29 CA CA002647465A patent/CA2647465A1/en not_active Abandoned
- 2007-03-29 CN CNA2007800182864A patent/CN101448518A/zh active Pending
-
2008
- 2008-10-14 ZA ZA200808768A patent/ZA200808768B/xx unknown
- 2008-10-28 NO NO20084525A patent/NO20084525L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20084525L (no) | 2008-11-28 |
EP2011509A2 (en) | 2009-01-07 |
BRPI0709922A2 (pt) | 2011-07-26 |
ZA200808768B (en) | 2009-07-29 |
CN101448518A (zh) | 2009-06-03 |
WO2007112703A2 (es) | 2007-10-11 |
MX2008012665A (es) | 2008-10-13 |
KR20080108576A (ko) | 2008-12-15 |
US20100129387A1 (en) | 2010-05-27 |
AR060797A1 (es) | 2008-07-16 |
CA2647465A1 (en) | 2007-10-11 |
AU2007234214A1 (en) | 2007-10-11 |
WO2007112703A3 (es) | 2008-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123152T1 (el) | Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους | |
McAuley et al. | Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease | |
Doherty et al. | Toward a broadly protective influenza vaccine | |
BR112016003358A2 (pt) | método para aumentar a expressão de proteínas codificadas por rna | |
BRPI0924460A2 (pt) | composição farmacêutica para uso em oftalmologia médica e veterinária | |
ECSP12011803A (es) | Polipéptidos inmunomoduladores derivados de la il-2 y su uso terapéutico en cáncer y en infecciones crónicas | |
BR112012022800A2 (pt) | composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica | |
BRPI0416796A (pt) | compostos orgánicos | |
WO2007022425A3 (en) | Influenza recombinant subunit vaccine | |
BR112014004860A2 (pt) | composições de anticorpo contra vírus da influenza | |
BRPI0906710B8 (pt) | peptídeo derivado de pres modificado hidrofóbico de vírus da hepatite b (hbv) , peptídeo e composição farmacêutica | |
ECSP12011959A (es) | SALES DE 4-[2-[[5-METIL-1-(2-NAFTALENIL)-1H-PIRAZOL-3-il]OXI]ETIL]MORFOLINA | |
BR112014001409A2 (pt) | métodos e composições para vacinação contra staphylococcus aureus | |
MX351380B (es) | Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino. | |
UA114719C2 (uk) | Рекомбінантний герпесвірус кої (khv) і вакцина для профілактики захворювання, що викликається khv | |
BR112014017141A2 (pt) | método de tratamento de diabetes usando-se apolipoproteína a-iv não glicosilada | |
EA201690115A1 (ru) | Комбинированные иммуногенные композиции | |
CU23572A1 (es) | Composición farmacéutica que comprende la proteína nmb0938 | |
BRPI0606614A2 (pt) | peptìdeos para distribuição de vacinas na mucosa | |
BRPI1012078A2 (pt) | construto de proteína, composição imunogênica, molécula de ácido nucleico , métodos de induzir uma resposta imune a casb7439 e de tratar um animal humano ou não-humano, e, uso de uma composição imunogênica | |
CU23575A1 (es) | Composición farmacéutica que comprende la proteína nmb0606 | |
CU23584A1 (es) | Composición farmacéutica que comprende la proteína nmb1796 | |
BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo | |
NZ712713A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
DK1981906T3 (da) | Human sædfremmer af virale infektionspeptider (SEVI) og deres anvendelse |